A Role for Genetic Modifiers in Tubulointerstitial Kidney Diseases

Genes (Basel). 2023 Aug 3;14(8):1582. doi: 10.3390/genes14081582.

Abstract

With the increased availability of genomic sequencing technologies, the molecular bases for kidney diseases such as nephronophthisis and mitochondrially inherited and autosomal-dominant tubulointerstitial kidney diseases (ADTKD) has become increasingly apparent. These tubulointerstitial kidney diseases (TKD) are monogenic diseases of the tubulointerstitium and result in interstitial fibrosis and tubular atrophy (IF/TA). However, monogenic inheritance alone does not adequately explain the highly variable onset of kidney failure and extra-renal manifestations. Phenotypes vary considerably between individuals harbouring the same pathogenic variant in the same putative monogenic gene, even within families sharing common environmental factors. While the extreme end of the disease spectrum may have dramatic syndromic manifestations typically diagnosed in childhood, many patients present a more subtle phenotype with little to differentiate them from many other common forms of non-proteinuric chronic kidney disease (CKD). This review summarises the expanding repertoire of genes underpinning TKD and their known phenotypic manifestations. Furthermore, we collate the growing evidence for a role of modifier genes and discuss the extent to which these data bridge the historical gap between apparently rare monogenic TKD and polygenic non-proteinuric CKD (excluding polycystic kidney disease).

Keywords: ADTKD; genetic modifiers; modifier genes; monogenic TKD; tubulointerstitial kidney disease.

Publication types

  • Review

MeSH terms

  • Chromosome Mapping
  • Genes, Modifier
  • Humans
  • Kidney
  • Polycystic Kidney Diseases*
  • Renal Insufficiency, Chronic*

Grants and funding

This review received no external funding.